CHRISTOPHER JOHN HELAL,EDDIE YANG,JOHN MICHAEL HUMPHREY,PATRICK ROBERT VERHOEST,THOMAS ALLEN CHAPPIE
申请号：
BR112013021366
公开号：
BR112013021366A2
申请日:
2012.02.09
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to compounds of the Formula and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal.
